Skip to main content

25/5 Logo Pill - pink three-sided, 8mm

Generic Name: empagliflozin/linagliptin

Pill with imprint 25/5 Logo is Pink, Three-sided and has been identified as Glyxambi empagliflozin 25 mg / linagliptin 5 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Glyxambi is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glyxambi empagliflozin 25 mg / linagliptin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 25/5 Logo

Glyxambi empagliflozin 25 mg / linagliptin 5 mg 25/5 Logo

Glyxambi

Generic Name
empagliflozin/linagliptin
Imprint
25/5 Logo
Strength
empagliflozin 25 mg / linagliptin 5 mg
Color
Pink
Size
8.00 mm
Shape
Three-sided
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
National Drug Code (NDC)
00597-0164

Get help with Imprint Code FAQs.

Related images for "25/5 Logo"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.